Skip to main content
padlock icon - secure page this page is secure

Peroxisome Proliferator-Activated Receptors as New Molecular Targets in Psoriasis

Buy Article:

$68.00 + tax (Refund Policy)

While psoriasis is upon the age of biological treatments, additional researches have led to other new therapies for psoriasis, including targets aimed at nuclear receptors. PPARs are members of the nuclearhormone- receptor superfamily, including retinoid receptors and vitamin D receptors. Recent works have highlighted the role of PPARs, which transduce a wide variety of signals into a set of cellular responses at the level of gene transcription, as critical regulators of cutaneous homeostasis in regulating differentiation, proliferation, and inflammatory responses of the skin. PPAR agonists or antagonists may therefore, hold promise as interesting compounds for the treatment of various epidermal disorders characterized by inflammation, hyperproliferation and aberrant differentiation, such as psoriasis.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: differentiation; inflammation; peroxisome proliferator-activated receptors; proliferation; psoriasis

Document Type: Review Article

Affiliations: Clinique de Dermatologie, Hopital Cantonal Universitaire, 24 rue Micheli-du-Crest, 1211 Geneve 14, Switzerland.

Publication date: June 1, 2004

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more